FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316171029> ?p ?o ?g. }

• W4316171029 endingPage "101746" @default.
• W4316171029 startingPage "101746" @default.
• W4316171029 abstract "Insomnia is one of the most common and burdensome disorders in adults. We compared and ranked insomnia medication on the basis of their efficacy and tolerability. We performed a systematic review and network meta-analysis of placebo-controlled or head-to-head randomized controlled trials for primary insomnia in adults comparing 20 drugs. We searched eight databases and seven trial registers from inception to March 1st, 2022. Primary outcomes included sleep latency (SL), awake time after sleep onset (WASO) and discontinuation for adverse events (AED), and secondary outcomes included total sleep time (TST), sleep efficiency (SE), sleep quality (SQ) and adverse events (ADE). Pooled standardized mean differences or odds ratios with 95% credible intervals were estimated using pairwise and network meta-analysis with random-effects. Differences among trial findings were explored in subgroup and sensitivity analyses. Confidence in evidence was assessed using GRADE. The PROSPERO registered number is CRD42020182144. We identified 22,538 records and included 69 studies (17,319 patients). Orexin receptor antagonists (ORAs) are more efficacious than benzodiazepine-like drugs (Z-drugs) and placebo for WASO and SE, and better than melatonin receptor agonists (MRAs) for SL, WASO and SE. ORAs ranked the best in SL (SUCRA value: 0.84), WASO (0.93), TST (0.86) and SE (0.96). Lemborexant and daridorexant (two ORAs) showed greater efficacy than placebo for SL, WASO, and TST, with good tolerability. Z-drugs were more efficacious than placebo for SL, WASO, TST and SE, but with higher risk to safety. Zaleplon and eszopiclone had better efficacy than placebo for TST and SQ respectively. MRAs may also be efficacious for sleep-onset insomnia with good safety. However, the long-term adverse effects of all medications are unclear. Insomnia medications differ in their efficacy and tolerability. ORAs have superior efficacy and tolerability. These findings should aid clinicians in matching risk/benefits of drugs available in their countries to insomnia symptoms." @default.
• W4316171029 created "2023-01-15" @default.
• W4316171029 creator A5002098877 @default.
• W4316171029 creator A5004762084 @default.
• W4316171029 creator A5006984203 @default.
• W4316171029 creator A5013037067 @default.
• W4316171029 creator A5022593632 @default.
• W4316171029 creator A5023578647 @default.
• W4316171029 creator A5047119592 @default.
• W4316171029 creator A5052714010 @default.
• W4316171029 creator A5053251331 @default.
• W4316171029 creator A5055807961 @default.
• W4316171029 creator A5066914963 @default.
• W4316171029 creator A5070223220 @default.
• W4316171029 creator A5070628952 @default.
• W4316171029 creator A5072229733 @default.
• W4316171029 creator A5077179362 @default.
• W4316171029 creator A5080295941 @default.
• W4316171029 creator A5081269023 @default.
• W4316171029 creator A5085717088 @default.
• W4316171029 date "2023-04-01" @default.
• W4316171029 modified "2023-10-11" @default.
• W4316171029 title "Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis" @default.
• W4316171029 cites W1617328014 @default.
• W4316171029 cites W1979882151 @default.
• W4316171029 cites W1985501047 @default.
• W4316171029 cites W2002669039 @default.
• W4316171029 cites W2010699829 @default.
• W4316171029 cites W2021124523 @default.
• W4316171029 cites W2035240111 @default.
• W4316171029 cites W2038637825 @default.
• W4316171029 cites W2058070208 @default.
• W4316171029 cites W2074147400 @default.
• W4316171029 cites W2077895426 @default.
• W4316171029 cites W2082850379 @default.
• W4316171029 cites W2082861010 @default.
• W4316171029 cites W2085803274 @default.
• W4316171029 cites W2144625636 @default.
• W4316171029 cites W2147717090 @default.
• W4316171029 cites W2151487996 @default.
• W4316171029 cites W2165010366 @default.
• W4316171029 cites W2332074126 @default.
• W4316171029 cites W2347166707 @default.
• W4316171029 cites W2539992626 @default.
• W4316171029 cites W2578164715 @default.
• W4316171029 cites W2587695521 @default.
• W4316171029 cites W2753866150 @default.
• W4316171029 cites W2788337440 @default.
• W4316171029 cites W2790038805 @default.
• W4316171029 cites W2887593062 @default.
• W4316171029 cites W2914189181 @default.
• W4316171029 cites W2957311488 @default.
• W4316171029 cites W2967986432 @default.
• W4316171029 cites W2970684805 @default.
• W4316171029 cites W3011743134 @default.
• W4316171029 cites W3015163167 @default.
• W4316171029 cites W3030975418 @default.
• W4316171029 cites W3215349399 @default.
• W4316171029 cites W4248040209 @default.
• W4316171029 cites W4285498627 @default.
• W4316171029 cites W4295775193 @default.
• W4316171029 cites W4383854511 @default.
• W4316171029 cites W615072721 @default.
• W4316171029 cites W3201375126 @default.
• W4316171029 doi "https://doi.org/10.1016/j.smrv.2023.101746" @default.
• W4316171029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36701954" @default.
• W4316171029 hasPublicationYear "2023" @default.
• W4316171029 type Work @default.
• W4316171029 citedByCount "11" @default.
• W4316171029 countsByYear W43161710292023 @default.
• W4316171029 crossrefType "journal-article" @default.
• W4316171029 hasAuthorship W4316171029A5002098877 @default.
• W4316171029 hasAuthorship W4316171029A5004762084 @default.
• W4316171029 hasAuthorship W4316171029A5006984203 @default.
• W4316171029 hasAuthorship W4316171029A5013037067 @default.
• W4316171029 hasAuthorship W4316171029A5022593632 @default.
• W4316171029 hasAuthorship W4316171029A5023578647 @default.
• W4316171029 hasAuthorship W4316171029A5047119592 @default.
• W4316171029 hasAuthorship W4316171029A5052714010 @default.
• W4316171029 hasAuthorship W4316171029A5053251331 @default.
• W4316171029 hasAuthorship W4316171029A5055807961 @default.
• W4316171029 hasAuthorship W4316171029A5066914963 @default.
• W4316171029 hasAuthorship W4316171029A5070223220 @default.
• W4316171029 hasAuthorship W4316171029A5070628952 @default.
• W4316171029 hasAuthorship W4316171029A5072229733 @default.
• W4316171029 hasAuthorship W4316171029A5077179362 @default.
• W4316171029 hasAuthorship W4316171029A5080295941 @default.
• W4316171029 hasAuthorship W4316171029A5081269023 @default.
• W4316171029 hasAuthorship W4316171029A5085717088 @default.
• W4316171029 hasConcept C118552586 @default.
• W4316171029 hasConcept C126322002 @default.
• W4316171029 hasConcept C142724271 @default.
• W4316171029 hasConcept C1513209611 @default.
• W4316171029 hasConcept C197934379 @default.
• W4316171029 hasConcept C204787440 @default.
• W4316171029 hasConcept C27081682 @default.
• W4316171029 hasConcept C2778375690 @default.
• W4316171029 hasConcept C2778715236 @default.

• next